Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Castagna

Showing results (131-140 of 203) with videos related to

Pageof 21
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 26, 2019
Peripheral Blood Stem Cells versus Bone Marrow for T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin LymphomaJacopo Mariotti, Raynier Devillier, Stefania Bramanti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2018
HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor ComparisonRaynier Devillier, Faezeh Legrand, Jérôme Rey, et al.
American Journal of Hematology|October 11, 2013
A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donorRaynier Devillier, Sabine Fürst, Roberto Crocchiolo, et al.
Transplantation and Cellular Therapy|April 5, 2021
Feasibility and Efficacy of CD45RA+ Depleted Donor Lymphocytes Infusion After Haploidentical Transplantation With Post-Transplantation Cyclophosphamide in Patients With Hematological MalignanciesLuca Castagna, Viviana Valli, Inna Timofeeva, et al.
Bone Marrow Transplantation|December 2, 2025
Unrelated donor transplantation for relapsed refractory aplastic anemia, with quadruple GvHD prophylaxisSabrina Giammarco, Andrea Bacigalupo, Nicola Mordini, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 31, 2013
Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell support for high-risk primary breast cancer: results from the Italian national registryPaolo Pedrazzoli, Giovanni Martinelli, Alessandro Massimo Gianni, et al.
Bone Marrow Transplantation|March 21, 2019
Peripheral blood stem cell for haploidentical transplantation with post-transplant high dose cyclophosphamide: detailed analysis of 181 consecutive patientsAngela Granata, Sabine Fürst, Stefania Bramanti, et al.
Cancer|August 16, 2012
Randomized study of 2 reduced-intensity conditioning strategies for human leukocyte antigen-matched, related allogeneic peripheral blood stem cell transplantation: prospective clinical and socioeconomic evaluationDidier Blaise, Reza Tabrizi, Jean-Marie Boher, et al.
Haematologica|April 28, 2018
The early expansion of anergic NKG2A<sup>pos</sup>/CD56<sup>dim</sup>/CD16<sup>neg</sup> natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantationAlessandra Roberto, Clara Di Vito, Elisa Zaghi, et al.
Bone Marrow Transplantation|October 13, 2020
Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party-EBMTLeyre Bento, Ariane Boumendil, Hervé Finel, et al.
Pageof 21

Showing results (131-140 of 203) with videos related to

Sort By:
Pageof 21
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 26, 2019
Peripheral Blood Stem Cells versus Bone Marrow for T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin LymphomaJacopo Mariotti, Raynier Devillier, Stefania Bramanti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2018
HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor ComparisonRaynier Devillier, Faezeh Legrand, Jérôme Rey, et al.
American Journal of Hematology|October 11, 2013
A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donorRaynier Devillier, Sabine Fürst, Roberto Crocchiolo, et al.
Transplantation and Cellular Therapy|April 5, 2021
Feasibility and Efficacy of CD45RA+ Depleted Donor Lymphocytes Infusion After Haploidentical Transplantation With Post-Transplantation Cyclophosphamide in Patients With Hematological MalignanciesLuca Castagna, Viviana Valli, Inna Timofeeva, et al.
Bone Marrow Transplantation|December 2, 2025
Unrelated donor transplantation for relapsed refractory aplastic anemia, with quadruple GvHD prophylaxisSabrina Giammarco, Andrea Bacigalupo, Nicola Mordini, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 31, 2013
Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell support for high-risk primary breast cancer: results from the Italian national registryPaolo Pedrazzoli, Giovanni Martinelli, Alessandro Massimo Gianni, et al.
Bone Marrow Transplantation|March 21, 2019
Peripheral blood stem cell for haploidentical transplantation with post-transplant high dose cyclophosphamide: detailed analysis of 181 consecutive patientsAngela Granata, Sabine Fürst, Stefania Bramanti, et al.
Cancer|August 16, 2012
Randomized study of 2 reduced-intensity conditioning strategies for human leukocyte antigen-matched, related allogeneic peripheral blood stem cell transplantation: prospective clinical and socioeconomic evaluationDidier Blaise, Reza Tabrizi, Jean-Marie Boher, et al.
Haematologica|April 28, 2018
The early expansion of anergic NKG2A<sup>pos</sup>/CD56<sup>dim</sup>/CD16<sup>neg</sup> natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantationAlessandra Roberto, Clara Di Vito, Elisa Zaghi, et al.
Bone Marrow Transplantation|October 13, 2020
Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party-EBMTLeyre Bento, Ariane Boumendil, Hervé Finel, et al.
Pageof 21